Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert G Hart

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
BMJ (Clinical Research Ed.)|November 2, 2002
Antithrombotic therapy for atrial fibrillationGregory Y H Lip, Robert G Hart, Dwayne S G Conway
Archives of Neurology|March 14, 2003
Late-developing cerebral arteropathy after pyogenic meningitisSantiago Palacio, Robert G Hart, Dennis G Vollmer, et al.
Stroke|July 25, 2012
Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trialsSantiago Palacio, Robert G Hart, Lesly A Pearce, et al.
Stroke|November 22, 2012
Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomesGustavo Saposnik, David Gladstone, Roula Raptis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Warfarin in atrial fibrillation patients with moderate chronic kidney diseaseRobert G Hart, Lesly A Pearce, Richard W Asinger, et al.
Stroke|March 3, 2007
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosisGregory Y H Lip, Jeetesh V Patel, Elizabeth Hughes, et al.
Postgraduate Medicine|January 17, 2013
Anticoagulants in patients with atrial fibrillation and end-stage renal diseaseK Scott Brimble, Alistair J Ingram, John W Eikelboom, et al.
The Canadian Journal of Cardiology|September 30, 2022
Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical TrialsRobert G Hart, Aristeidis H Katsanos, Kanjana S Perera, et al.
Nature Reviews. Nephrology|July 25, 2012
Anticoagulants in atrial fibrillation patients with chronic kidney diseaseRobert G Hart, John W Eikelboom, Alistair J Ingram, et al.
Annals of Emergency Medicine|March 30, 2005
Data and safety monitoring in clinical research: a National Institute of Neurologic Disorders and Stroke perspectiveRobin A Conwit, Robert G Hart, Claudia S Moy, et al.
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
BMJ (Clinical Research Ed.)|November 2, 2002
Antithrombotic therapy for atrial fibrillationGregory Y H Lip, Robert G Hart, Dwayne S G Conway
Archives of Neurology|March 14, 2003
Late-developing cerebral arteropathy after pyogenic meningitisSantiago Palacio, Robert G Hart, Dennis G Vollmer, et al.
Stroke|July 25, 2012
Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trialsSantiago Palacio, Robert G Hart, Lesly A Pearce, et al.
Stroke|November 22, 2012
Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomesGustavo Saposnik, David Gladstone, Roula Raptis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Warfarin in atrial fibrillation patients with moderate chronic kidney diseaseRobert G Hart, Lesly A Pearce, Richard W Asinger, et al.
Stroke|March 3, 2007
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosisGregory Y H Lip, Jeetesh V Patel, Elizabeth Hughes, et al.
Postgraduate Medicine|January 17, 2013
Anticoagulants in patients with atrial fibrillation and end-stage renal diseaseK Scott Brimble, Alistair J Ingram, John W Eikelboom, et al.
The Canadian Journal of Cardiology|September 30, 2022
Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical TrialsRobert G Hart, Aristeidis H Katsanos, Kanjana S Perera, et al.
Nature Reviews. Nephrology|July 25, 2012
Anticoagulants in atrial fibrillation patients with chronic kidney diseaseRobert G Hart, John W Eikelboom, Alistair J Ingram, et al.
Annals of Emergency Medicine|March 30, 2005
Data and safety monitoring in clinical research: a National Institute of Neurologic Disorders and Stroke perspectiveRobin A Conwit, Robert G Hart, Claudia S Moy, et al.
Pageof 21